Literature DB >> 10207054

Ubiquitination and degradation of ATF2 are dimerization dependent.

S Y Fuchs1, Z Ronai.   

Abstract

Ubiquitination and proteasome-dependent degradation are key determinants of the half-lives of many transcription factors. Homo- or heterodimerization of basic region-leucine zipper (bZIP) transcription factors is required for their transcriptional activities. Here we show that activating transcription factor 2 (ATF2) heterodimerization with specific bZIP proteins is an important determinant of the ubiquitination and proteasome-dependent degradation of ATF2. Depletion of c-Jun as one of the ATF2 heterodimer partners from the targeting proteins decreased the efficiency of ATF2 ubiquitination in vitro, whereas the addition of exogenously purified c-Jun restored it. Similarly, overexpression of c-Jun in 293T human embryo kidney cells increased ATF2 ubiquitination in vivo and reduced its half-life in a dose-dependent manner. Mutations of ATF2 that disrupt its dimerization inhibited ATF2 ubiquitination in vitro and in vivo. Conversely, removal of residues 150 to 248, as in a constitutively active ATF2 spliced form, enhanced ATF2 dimerization and transactivation, which coincided with increased ubiquitination and decreased stability. Our findings indicate the increased sensitivity of transcriptionally active dimers of ATF2 to ubiquitination and proteasome-dependent degradation. Based on these observations, we conclude that increased targeting of a transcriptionally active ATF2 form indicates the mechanism by which the magnitude and the duration of the cellular stress response are regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207054      PMCID: PMC84123          DOI: 10.1128/MCB.19.5.3289

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer.

Authors:  K Georgopoulos; B A Morgan; D D Moore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Selective interaction of JNK protein kinase isoforms with transcription factors.

Authors:  S Gupta; T Barrett; A J Whitmarsh; J Cavanagh; H K Sluss; B Dérijard; R J Davis
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  In vivo association of ATFa with JNK/SAP kinase activities.

Authors:  J L Bocco; A Bahr; J Goetz; C Hauss; T Kallunki; C Kedinger; B Chatton
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

4.  A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein.

Authors:  F Liu; M R Green
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase.

Authors:  S Y Fuchs; L Dolan; R J Davis; Z Ronai
Journal:  Oncogene       Date:  1996-10-03       Impact factor: 9.867

6.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.

Authors:  J Raingeaud; A J Whitmarsh; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Heterodimer formation between CREB and JUN proteins.

Authors:  D M Benbrook; N C Jones
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

8.  HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions.

Authors:  H F Maguire; J P Hoeffler; A Siddiqui
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

9.  Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription.

Authors:  H F Yang-Yen; R Chiu; M Karin
Journal:  New Biol       Date:  1990-04

10.  Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain.

Authors:  T Maekawa; H Sakura; C Kanei-Ishii; T Sudo; T Yoshimura; J Fujisawa; M Yoshida; S Ishii
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  24 in total

1.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

Review 2.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

3.  Requirements for PKC-augmented JNK activation by MKK4/7.

Authors:  Pablo Lopez-Bergami; Ze'ev Ronai
Journal:  Int J Biochem Cell Biol       Date:  2007-12-03       Impact factor: 5.085

Review 4.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.

Authors:  Gregory Watson; Ze'ev A Ronai; Eric Lau
Journal:  Pharmacol Res       Date:  2017-02-15       Impact factor: 7.658

Review 5.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

6.  cJun and CREB2 in the postsynaptic neuron contribute to persistent long-term facilitation at a behaviorally relevant synapse.

Authors:  Jiang-Yuan Hu; Amir Levine; Ying-Ju Sung; Samuel Schacher
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

7.  Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.

Authors:  Vladimir Majerciak; Natalia Pripuzova; Calvin Chan; Nicholas Temkin; Suzanne I Specht; Zhi-Ming Zheng
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

8.  Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies.

Authors:  Zhen Lu; Angelica Ortiz; Ioannis I Verginadis; Amy R Peck; Farima Zahedi; Christina Cho; Pengfei Yu; Rachel M DeRita; Hongru Zhang; Ryan Kubanoff; Yunguang Sun; Andrew T Yaspan; Elise Krespan; Daniel P Beiting; Enrico Radaelli; Sandra W Ryeom; J Alan Diehl; Hallgeir Rui; Constantinos Koumenis; Serge Y Fuchs
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

9.  ATF2 - at the crossroad of nuclear and cytosolic functions.

Authors:  Eric Lau; Ze'ev A Ronai
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

10.  RACK1 mediates activation of JNK by protein kinase C [corrected].

Authors:  Pablo López-Bergami; Hasem Habelhah; Anindita Bhoumik; Weizhou Zhang; Lu-Hai Wang; Ze'ev Ronai
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.